Home > Boards > US OTC > Miscellaneous > Cannapharmarx Inc. (CPMD)

Initial Statement of Beneficial Ownership (3) Source: Edgar (US

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
getshort Member Profile
 
Followed By 1
Posts 203
Boards Moderated 0
Alias Born 09/14/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2020 3:05:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2020 4:32:33 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2020 9:14:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2020 6:32:34 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/29/2020 2:53:35 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/29/2020 12:23:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2020 1:26:45 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/22/2020 2:13:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/19/2020 11:23:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2020 11:42:04 AM
Annual Report (10-k) Edgar (US Regulatory) - 5/27/2020 1:48:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2020 12:03:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 8:33:08 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 5/14/2020 8:31:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/29/2020 7:41:28 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 4/29/2020 7:39:23 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/29/2020 9:09:51 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2020 6:01:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/17/2020 3:37:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/10/2020 2:30:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2020 2:45:48 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/4/2020 6:39:22 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/4/2020 5:08:35 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 2/3/2020 6:20:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/3/2020 4:56:43 PM
getshort   Monday, 10/01/18 01:34:45 PM
Re: georgie18 post# 79
Post # of 121 
Initial Statement of Beneficial Ownership (3)

Source: Edgar (US Regulatory)
FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person *
SAMUELSON JAMES F

2. Date of Event Requiring Statement (MM/DD/YYYY)
4/20/2018

3. Issuer Name and Ticker or Trading Symbol
CANNAPHARMARX, INC. [CPMD```]

(Last) (First) (Middle)
PO BOX 22

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)
NEWPORT BEACH, CA 92662

(City) (State) (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)



6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 2. Amount of Securities Beneficially Owned
(Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock (1) 4/20/2018 (2) Common Stock 25000000 $0 D

Explanation of Responses:
(1) Reporting Person acquired 20,000 shares of Series A Convertible Preferred Stock, each share convertible into 1,250 shares of Common Stock of the Issuer.
(2) The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SAMUELSON JAMES F
PO BOX 22
NEWPORT BEACH, CA 92662 X



Signatures
James F. Samuelson 9/20/2018
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences